首页 › 基金 › Virtus Wealth Solutions LLC › AMRX

Virtus Wealth Solutions LLC 对 AMRX 的持仓历史

AMNEAL PHARMACEUTICALS INC · 医疗保健

Virtus Wealth Solutions LLC 在 Q3 2026 的 13F 申报中披露持有 AMRX(AMNEAL PHARMACEUTICALS INC)159,140 股,市值约 US$3.2M,约占其申报组合的 0.54%,在其申报持仓中市值排名第 23 位。 Virtus Wealth Solutions LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)159.14K 股
申报持仓市值$3.21M
组合权重0.54%
首次申报Q3 2026
最近变动新进
更新于2026-11-03

最后更新: 2026-11-03 · 来源: SEC EDGAR Form 13F-HR

Virtus Wealth Solutions LLC 对 AMRX 的持仓演变

Virtus Wealth Solutions LLC 于 Q3 2026 首次披露 AMRX 持仓:159,140 股(约 US$3.2M)。

逐季持仓明细

季度股数金额变化
Q3 2026 159.14K $3.21M 新进

关于 AMRX 与 13F 数据

AMRX(AMNEAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 AMRX,申报仓位最大的包括:TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AMRX 的基金

查看 AMRX 的全部基金持有人 →

常见问题

How long has Virtus Wealth Solutions LLC held AMRX?

Virtus Wealth Solutions LLC has disclosed AMRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Virtus Wealth Solutions LLC's current position in AMRX?

As of Q3 2026, Virtus Wealth Solutions LLC holds 159.14K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $3.21M, representing 0.54% of its reported portfolio and ranking #23.

Has Virtus Wealth Solutions LLC been buying or selling AMRX?

In the latest 13F filing (Q3 2026), Virtus Wealth Solutions LLC newly opened its position in AMRX.

Which other funds hold AMRX?

Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.